M
MAZE//CIK 0001842295
Maze Therapeutics, Inc.
Market Data
$28.12+$3.28 (+13.20%)
MAZE · Last trade
Prev Close
$24.84
Range (29d)
$25.57 – $32.84
Recent Filings
- 8-K150.3 KBMaze Therapeutics, Inc.Jun 10, 4:15 PM ET·0001193125-26-265858
- 8-K139.4 KBMaze Therapeutics, Inc.May 22, 5:24 PM ET·0001193125-26-237199
- 10-Q9.1 MBMaze Therapeutics, Inc.May 12, 4:11 PM ET·0001193125-26-219430
- 8-K281.8 KBMaze Therapeutics, Inc.May 12, 4:07 PM ET·0001193125-26-219398
- 8-K675.7 KBMaze Therapeutics, Inc.Apr 22, 4:56 PM ET·0001193125-26-170701
- 10-K16.7 MBMaze Therapeutics, Inc.Mar 25, 7:11 AM ET·0001193125-26-122778
- 8-K449.9 KBMaze Therapeutics, Inc.Mar 25, 7:08 AM ET·0001193125-26-122774
- 8-K152.5 KBMaze Therapeutics, Inc.Feb 4, 4:45 PM ET·0001193125-26-037747
- 10-Q9.6 MBMaze Therapeutics, Inc.Nov 6, 4:27 PM ET·0001193125-25-269689
- 8-K381.5 KBMaze Therapeutics, Inc.Nov 6, 4:21 PM ET·0001193125-25-269624
Insiders
10- Andrews Nancy CDirector
- ARCH Venture Fund X, L.P.10% Owner
- ARCH Venture Partners X, LLC10% Owner
- Bachrodt AmySVP, Finance
- Bernstein HaroldPresident, R&D & CMO
- Brush JamesDirector
- Burow Kristina10% Owner
- Coloma Jason VDirector, Chief Executive Officer
- Colowick AlanDirector
- Courtney PhillipsGC and Corp. Secretary
Tickers
Addresses
business
171 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
mailing
171 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO, CA, 94080